• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Raptiva Rolls Out

Article

San Francisco ?? Sources familiar with Raptiva (efalizumab) hail its approval by the U.S. Food and Drug Administration last month as nothing but an enhancement to patient compliance and successful treatment of chronic moderate-to-severe plaque psoriasis.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.